Another study clarified that the combination of artesunate with WNT974 (a WNT inhibitor) induces the proteasomal degradation of overexpressed oncoprotein KRAS in CRC via significantly upregulating E3 ligase ANACP2 and β-TrCP [78]. The gene discussed is BTRC; the disease is colorectal carcinoma.